dc.contributor.author | Yazici, Halil | |
dc.contributor.author | Turkmen, Aydin | |
dc.contributor.author | Carin, Mahmut Nezih | |
dc.contributor.author | Aydin, Ali Emin | |
dc.contributor.author | Oguz, Fatma Savran | |
dc.contributor.author | Onal, Ayşe Emel | |
dc.contributor.author | Sever, Mehmet Sukru | |
dc.contributor.author | Eldegez, Ulug | |
dc.contributor.author | Kekik, Cigdem | |
dc.contributor.author | Karahan, Gonca Emel | |
dc.contributor.author | Seyhun, Yalcin | |
dc.date.accessioned | 2021-03-04T19:25:36Z | |
dc.date.available | 2021-03-04T19:25:36Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Karahan G. E. , Seyhun Y., Oguz F. S. , Kekik C., Onal A. E. , Yazici H., Turkmen A., Aydin A. E. , Sever M. S. , Eldegez U., et al., "Impact of HLA on the Underlying Primary Diseases in Turkish Patients with End-Stage Renal Disease", RENAL FAILURE, cilt.31, ss.44-49, 2009 | |
dc.identifier.issn | 0886-022X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_8fb7f22f-5dea-4555-a74d-3fe694a70eac | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/97039 | |
dc.identifier.uri | https://doi.org/10.1080/08860220802546297 | |
dc.description.abstract | The number of patients with end stage renal disease (ESRD) is increasing faster than the number of renal transplantations performed per year worldwide. Of the primary diseases leading to ESRD, diabetic nephropathy is the leading cause. The purpose of the present study is to investigate the association of HLA with the primary diseases leading to ESRD in Turkish patients. A total of 3230 individuals comprising 587 ESRD patients and 2643 healthy controls were enrolled into the study. Class I HLA-A, -B typing was performed by CDC method, while class II HLA-DRB1 typing was performed by low resolution PCR-SSP. We found a significant negative association between almost all A locus antigens and primary disease groups classified as chronic glomerulonephritis and hypertensive nephrosclerosis (p 0.05). HLA-B58 and HLA-DRB1*03 significantly correlated with amyloidosis and diabetic nephropathy, respectively. Determination of HLAs as risk factors for primary diseases leading to ESRD might be beneficial in preventing progression to ESRD and recurrence of the primary disease post-transplantation. | |
dc.language.iso | eng | |
dc.subject | Nefroloji | |
dc.subject | ÜROLOJİ VE NEFROLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.title | Impact of HLA on the Underlying Primary Diseases in Turkish Patients with End-Stage Renal Disease | |
dc.type | Makale | |
dc.relation.journal | RENAL FAILURE | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 31 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 44 | |
dc.identifier.endpage | 49 | |
dc.contributor.firstauthorID | 30204 | |